Company Media
No crap: Immuron is one step closer to an anti-gastro pill
16 July 2018
Big Pharma is watching as Immuron edges towards trial results
26 June 2018
Immuron reports positive clinical study results in the fight against fatty liver disease
8 March 2018
Shares in Australian pharma Immuron are going nuts
8 March 2018
Immuron's IMM-124E shows encouraging action in mid-stage NASH study; shares ahead 81%
8 March 2018
Immuron’s shares surge on demonstrating proof of concept for liver drug candidate
8 March 2018
Results in: IMC’s lead drug reduces major factor in liver inflammation
8 March 2018
Blockbuster Results from IMC’s NASH Liver Therapy Trials
8 March 2018
Immuron reduces liver inflammation
2 March 2018
How Do You Recruit Patients Unaware Of Their Disease?
1 March 2018
Immuron's fatty liver disease candidate advancing — 4 insights
14 September 2017
In dash to NASH, Immuron targets the gut not the liver
28 March 2017
Biotech tackles hospital infection
17 March 2017